These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31624984)

  • 1. Cinnamaldehyde: a compound with antimicrobial and synergistic activity against ESBL-producing quinolone-resistant pathogenic Enterobacteriaceae.
    Dhara L; Tripathi A
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):65-73. PubMed ID: 31624984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of eugenol in combination with cefotaxime and ciprofloxacin to combat ESBL-producing quinolone-resistant pathogenic Enterobacteriaceae.
    Dhara L; Tripathi A
    J Appl Microbiol; 2020 Dec; 129(6):1566-1576. PubMed ID: 32502298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of genetic factors towards cefotaxime and ciprofloxacin resistance development among Extended spectrum beta-lactamase producing-Quinolone resistant pathogenic Enterobacteriaceae.
    Dhara L; Tripathi A
    Gene; 2024 Jan; 893():147921. PubMed ID: 37884102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sub-acute toxicological and behavioural effects of two candidate therapeutics, cinnamaldehyde and eugenol, for treatment of ESBL producing-quinolone resistant pathogenic Enterobacteriaceae.
    Dhara L; Tripathi A
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):977-988. PubMed ID: 32027395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of acquired quinolone-resistance genes among Enterobacteriaceae from Saudi Arabia with CTX-M-15 β-lactamase.
    Shibl AM; Al-Agamy MH; Khubnani H; Senok AC; Tawfik AF; Livermore DM
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):350-3. PubMed ID: 22633335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from blood cultures in Liverpool, UK.
    Corkill JE; Anson JJ; Hart CA
    J Antimicrob Chemother; 2005 Dec; 56(6):1115-7. PubMed ID: 16260446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of extended spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis in Okinawa prefecture, Japan.
    Nakama R; Shingaki A; Miyazato H; Higa R; Nagamoto C; Hamamoto K; Ueda S; Hachiman T; Touma Y; Miyagi K; Kawahara R; Toyosato T; Hirai I
    J Infect Chemother; 2016 May; 22(5):281-6. PubMed ID: 26898665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.
    Reuland EA; Sonder GJ; Stolte I; Al Naiemi N; Koek A; Linde GB; van de Laar TJ; Vandenbroucke-Grauls CM; van Dam AP
    Clin Microbiol Infect; 2016 Aug; 22(8):731.e1-7. PubMed ID: 27223840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia.
    Vlieghe ER; Huang TD; Phe T; Bogaerts P; Berhin C; De Smet B; Peetermans WE; Jacobs JA; Glupczynski Y
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1223-9. PubMed ID: 25717021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of bactericidal and synergistic activity of quercetin with meropenem among pathogenic carbapenem resistant Escherichia coli and Klebsiella pneumoniae.
    Pal A; Tripathi A
    Microb Pathog; 2020 Jun; 143():104120. PubMed ID: 32169488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.
    López-Hernández I; Alonso N; Fernández-Martínez M; Zamorano L; Rivera A; Oliver A; Conejo MC; Martínez-Martínez L; Navarro F; Pascual A
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):499-504. PubMed ID: 27887765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-spectrum beta-lactamases and the permeability barrier.
    Martínez-Martínez L
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():82-9. PubMed ID: 18154531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.
    Tello M; Ocejo M; Oporto B; Hurtado A
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32471914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of
    Benameur Q; Gervasi T; Pellizzeri V; Pľuchtová M; Tali-Maama H; Assaous F; Guettou B; Rahal K; Gruľová D; Dugo G; Marino A; Ben-Mahdi MH
    Nat Prod Res; 2019 Sep; 33(18):2647-2654. PubMed ID: 29726697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of Enterobacteriaceae co-producing CTX-M-15, ArmA and PMQR in Poland.
    Piekarska K; Zacharczuk K; Wołkowicz T; Wolaniuk N; Rzeczkowska M; Gierczyński R
    Adv Clin Exp Med; 2019 Feb; 28(2):249-254. PubMed ID: 30499638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S; Gaind R; Ranjan R; Deb M
    J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates.
    Al-Zarouni M; Senok A; Rashid F; Al-Jesmi SM; Panigrahi D
    Med Princ Pract; 2008; 17(1):32-6. PubMed ID: 18059098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.